SCHEMBL14948561

SCHEMBL14948561

C[C@H](O)[C@@H](O)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29888723 1.00
SCHEMBL11031370 1.00
SCHEMBL9765967 1.00
SCHEMBL1926252 1.00
SCHEMBL50023 1.00
Ethane SCHEMBL16390773 0.96
Ammonia Solution, Strong SCHEMBL9545199 0.96
Methoxymethane SCHEMBL2230632 0.90 TDP1 (0.44)
Glycerin SCHEMBL27514435 0.90 LMNA (0.56)
Bicarbonate SCHEMBL29012506 0.87 PDE4A (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220304941-A1 COMPOSITION FOR PREVENTING OR TREATING ORAL DISEASES TECOZYME INC (KR) 2022-09-29 US claimed
US-20220304941-A1 COMPOSITION FOR PREVENTING OR TREATING ORAL DISEASES TECOZYME INC (KR) 2022-09-29 US disclosed
US-8921373-B2 Compounds having TRPV1 antagonistic activity and uses thereof SHIONOGI & CO., LTD. (JP) 2014-12-30 US disclosed
US-20130123239-A1 COMPOUNDS HAVING TRPV1 ANTAGONISTIC ACTIVITY AND USES THEREOF PURDUE PHARMA L.P. 2013-05-16 US disclosed